CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-15 | Mohan Pankaj Director | Purchase | +8,000 | $0.68 | $5K | 7,064,553 |
| 2018-11-09 | Mohan Pankaj Director | Grant or award · Stock Option (Right to Buy) | +114,157 | $0.61 | $70K | 114,157 |
| 2018-09-21 | Mohan Pankaj Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-01-04 | Mohan Pankaj President & CEO | Sale | −62,569 | $1.16 | $73K | 7,056,553 |
| 2018-01-03 | Mohan Pankaj President & CEO | Sale | −52,108 | $1.18 | $61K | 7,119,122 |
| 2017-12-19 | Mohan Pankaj President & CEO | Sale | −83,608 | $1.14 | $95K | 7,171,230 |
| 2017-12-18 | Mohan Pankaj President & CEO | Sale | −20,523 | $1.17 | $24K | 7,254,838 |
| 2016-05-18 | Mohan Pankaj President & CEO | Conversion · Series A Preferred Stock | −106 | 0 | ||
| 2016-05-11 | Mohan Pankaj President & CEO | Conversion | +17,666 | 39,405 |
Page 1 of 1 · 9 trades